Hypersensitivity to cyclosporine (Neoral) and successful desensitization.
Sumpton
J E
JE
Pharmacy Department, London Health Sciences Centre, Victoria Campus, London, Ontario, Canada. janice.sumpton@lhsc.on.ca
White
C T
CT
Rieder
M J
MJ
D'Souza
S J
SJ
D000284:Administration, Oral; D002675:Child, Preschool; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003888:Desensitization, Immunologic / Q000379:methods*; D004342:Drug Hypersensitivity / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009404:Nephrotic Syndrome / Q000188:drug therapy*
D007166:Immunosuppressive Agents; D016572:Cyclosporine